{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Mebhydrolin  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Mebhydrolin. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Mebhydrolin  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "mebhydrolin",
    "trial_2_text": "Mebhydrolin  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Mebhydrolin Supplement: 60 participants will take Mebhydrolin 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Mebhydrolin. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Mebhydrolin  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.22562117874622345,
      "78": 0.20213842391967773,
      "177": 0.16826395690441132,
      "123": 0.14814168214797974,
      "37": 0.14476870000362396,
      "20": 0.1433105170726776,
      "17": 0.13746504485607147,
      "21": 0.13451774418354034,
      "173": 0.1298713982105255,
      "46": 0.12621630728244781,
      "14": 0.12421628832817078,
      "68": 0.1217191070318222,
      "77": 0.1197730004787445,
      "49": 0.11220613867044449,
      "9": 0.11195360124111176,
      "2": 0.10921625792980194,
      "67": 0.10647743195295334,
      "79": 0.10588912665843964,
      "189": 0.10215125232934952,
      "200": 0.09782499074935913,
      "228": 0.0974770113825798,
      "350": 0.09637602418661118,
      "114": 0.09501299262046814,
      "188": 0.09103373438119888,
      "5": 0.08130843192338943,
      "101": 0.07736972719430923,
      "193": 0.07669708877801895,
      "64": 0.07441316545009613,
      "85": 0.07401139289140701,
      "243": 0.07116813957691193,
      "29": 0.0706879273056984,
      "126": 0.06959235668182373,
      "86": 0.06741500645875931,
      "27": 0.06637474149465561,
      "104": 0.06627398729324341,
      "76": 0.06518132239580154,
      "239": 0.064756378531456,
      "61": 0.06424570828676224,
      "180": 0.06409287452697754,
      "28": 0.06342410296201706,
      "18": 0.06114170700311661,
      "72": 0.0611233226954937,
      "179": 0.058346208184957504,
      "131": 0.058006469160318375,
      "82": 0.05787259712815285,
      "116": 0.055501677095890045,
      "194": 0.05547507479786873,
      "144": 0.055133525282144547,
      "102": 0.05407136306166649,
      "69": 0.05323628708720207,
      "139": 0.05320485308766365,
      "276": 0.05319241061806679,
      "30": 0.052007321268320084,
      "151": 0.05146851763129234,
      "396": 0.050671957433223724,
      "147": 0.05033349245786667,
      "261": 0.04914445802569389,
      "186": 0.04864530265331268,
      "204": 0.047728899866342545,
      "1": 0.047525323927402496,
      "122": 0.04651952534914017,
      "253": 0.046321846544742584,
      "191": 0.046055715531110764,
      "38": 0.0447903610765934,
      "282": 0.04390054568648338,
      "234": 0.0431990809738636,
      "269": 0.04303014278411865,
      "92": 0.04260627552866936,
      "288": 0.04203389212489128,
      "35": 0.041634708642959595,
      "75": 0.04136805608868599,
      "130": 0.04111403599381447,
      "355": 0.040670063346624374,
      "508": 0.04030020534992218,
      "4": 0.039667002856731415,
      "96": 0.039662208408117294,
      "466": 0.0394943505525589,
      "153": 0.039408400654792786,
      "164": 0.03885994479060173,
      "262": 0.03859458118677139,
      "221": 0.038096413016319275,
      "132": 0.0374104380607605,
      "454": 0.037279024720191956,
      "97": 0.037232011556625366,
      "339": 0.0371745266020298,
      "382": 0.037130206823349,
      "441": 0.03661269322037697,
      "249": 0.036340102553367615,
      "212": 0.03566789627075195,
      "341": 0.03561114892363548,
      "286": 0.03544514626264572,
      "199": 0.03471371904015541,
      "163": 0.034439630806446075,
      "211": 0.03414227440953255,
      "33": 0.03379247337579727,
      "142": 0.03314412757754326,
      "422": 0.03282715752720833,
      "11": 0.03280958533287048,
      "400": 0.03254837542772293,
      "138": 0.03199445828795433
    },
    "trial_2_ae": {
      "87": 0.22562117874622345,
      "78": 0.20213842391967773,
      "177": 0.16826395690441132,
      "123": 0.14814168214797974,
      "37": 0.14476870000362396,
      "20": 0.1433105170726776,
      "17": 0.13746504485607147,
      "21": 0.13451774418354034,
      "173": 0.1298713982105255,
      "46": 0.12621630728244781,
      "14": 0.12421628832817078,
      "68": 0.1217191070318222,
      "77": 0.1197730004787445,
      "49": 0.11220613867044449,
      "9": 0.11195360124111176,
      "2": 0.10921625792980194,
      "67": 0.10647743195295334,
      "79": 0.10588912665843964,
      "189": 0.10215125232934952,
      "200": 0.09782499074935913,
      "228": 0.0974770113825798,
      "350": 0.09637602418661118,
      "114": 0.09501299262046814,
      "188": 0.09103373438119888,
      "5": 0.08130843192338943,
      "101": 0.07736972719430923,
      "193": 0.07669708877801895,
      "64": 0.07441316545009613,
      "85": 0.07401139289140701,
      "243": 0.07116813957691193,
      "29": 0.0706879273056984,
      "126": 0.06959235668182373,
      "86": 0.06741500645875931,
      "27": 0.06637474149465561,
      "104": 0.06627398729324341,
      "76": 0.06518132239580154,
      "239": 0.064756378531456,
      "61": 0.06424570828676224,
      "180": 0.06409287452697754,
      "28": 0.06342410296201706,
      "18": 0.06114170700311661,
      "72": 0.0611233226954937,
      "179": 0.058346208184957504,
      "131": 0.058006469160318375,
      "82": 0.05787259712815285,
      "116": 0.055501677095890045,
      "194": 0.05547507479786873,
      "144": 0.055133525282144547,
      "102": 0.05407136306166649,
      "69": 0.05323628708720207,
      "139": 0.05320485308766365,
      "276": 0.05319241061806679,
      "30": 0.052007321268320084,
      "151": 0.05146851763129234,
      "396": 0.050671957433223724,
      "147": 0.05033349245786667,
      "261": 0.04914445802569389,
      "186": 0.04864530265331268,
      "204": 0.047728899866342545,
      "1": 0.047525323927402496,
      "122": 0.04651952534914017,
      "253": 0.046321846544742584,
      "191": 0.046055715531110764,
      "38": 0.0447903610765934,
      "282": 0.04390054568648338,
      "234": 0.0431990809738636,
      "269": 0.04303014278411865,
      "92": 0.04260627552866936,
      "288": 0.04203389212489128,
      "35": 0.041634708642959595,
      "75": 0.04136805608868599,
      "130": 0.04111403599381447,
      "355": 0.040670063346624374,
      "508": 0.04030020534992218,
      "4": 0.039667002856731415,
      "96": 0.039662208408117294,
      "466": 0.0394943505525589,
      "153": 0.039408400654792786,
      "164": 0.03885994479060173,
      "262": 0.03859458118677139,
      "221": 0.038096413016319275,
      "132": 0.0374104380607605,
      "454": 0.037279024720191956,
      "97": 0.037232011556625366,
      "339": 0.0371745266020298,
      "382": 0.037130206823349,
      "441": 0.03661269322037697,
      "249": 0.036340102553367615,
      "212": 0.03566789627075195,
      "341": 0.03561114892363548,
      "286": 0.03544514626264572,
      "199": 0.03471371904015541,
      "163": 0.034439630806446075,
      "211": 0.03414227440953255,
      "33": 0.03379247337579727,
      "142": 0.03314412757754326,
      "422": 0.03282715752720833,
      "11": 0.03280958533287048,
      "400": 0.03254837542772293,
      "138": 0.03199445828795433
    }
  },
  "safety": {
    "trial_1_safety": 0.33052340149879456,
    "trial_2_safety": 0.33052340149879456
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47896608710289
  }
}